• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物生物技术大麻素生产的当前观点。

Current Perspectives on Biotechnological Cannabinoid Production in Plants.

机构信息

Laboratory of Technical Biochemistry, Department of Biochemical and Chemical Engineering, TU Dortmund University, Dortmund, Germany.

Plant Biotechnology and Metabolic Engineering, Technische Universität Darmstadt, Darmstadt, Germany.

出版信息

Planta Med. 2018 Mar;84(4):214-220. doi: 10.1055/s-0043-125087. Epub 2018 Jan 4.

DOI:10.1055/s-0043-125087
PMID:29301148
Abstract

The plant contains a number of psychoactive chemical compounds, the cannabinoids, which possess a significant pharmaceutical potential. Recently, the usage of for medicinal purposes was legalized in many countries. Thus, the study on the influence of different cannabinoids in combination with other -derived compounds with respect to the treatment of various diseases becomes increasingly important. Besides the production of distinct cannabinoids in a heterologous host, like tobacco or yeast, transgenic plants would be a suitable alternative to modify and therefore optimize the cannabinoid profile. This perspective highlights the current efforts on cell culture systems, propagation, and transformation of the plant and reveals the resulting opportunities concerning biotechnological production of cannabinoids. Furthermore, alternative platform organisms for the heterologous production of cannabinoids, like tobacco, are considered and evaluated.

摘要

该植物含有多种具有显著药用潜力的精神活性化学化合物,即大麻素。最近,许多国家已经将大麻用于医疗目的合法化。因此,研究不同大麻素与其他衍生化合物的组合对各种疾病的治疗作用变得越来越重要。除了在烟草或酵母等异源宿主中生产不同的大麻素外,转基因大麻植物也是一种合适的替代方法,可以对其进行修饰和优化大麻素的特征。这一观点强调了当前在大麻细胞培养系统、繁殖和转化方面的努力,并揭示了在大麻素生物制造方面的相关机会。此外,还考虑和评估了烟草等用于大麻素异源生产的替代平台生物。

相似文献

1
Current Perspectives on Biotechnological Cannabinoid Production in Plants.植物生物技术大麻素生产的当前观点。
Planta Med. 2018 Mar;84(4):214-220. doi: 10.1055/s-0043-125087. Epub 2018 Jan 4.
2
Designing microorganisms for heterologous biosynthesis of cannabinoids.设计微生物用于大麻素的异源生物合成。
FEMS Yeast Res. 2017 Jun 1;17(4). doi: 10.1093/femsyr/fox037.
3
Recent advances in Cannabis sativa research: biosynthetic studies and its potential in biotechnology.大麻研究的最新进展:生物合成研究及其在生物技术中的潜力。
Curr Pharm Biotechnol. 2007 Aug;8(4):237-43. doi: 10.2174/138920107781387456.
4
Current status and future prospects in cannabinoid production through in vitro culture and synthetic biology.通过体外培养和合成生物学生产大麻素的现状与未来展望
Biotechnol Adv. 2023 Jan-Feb;62:108074. doi: 10.1016/j.biotechadv.2022.108074. Epub 2022 Dec 5.
5
Subcellular localization defines modification and production of Δ-tetrahydrocannabinolic acid synthase in transiently transformed Nicotiana benthamiana.亚细胞定位决定了瞬时转化的本氏烟草中Δ-四氢大麻酚酸合酶的修饰和产生。
Biotechnol Lett. 2018 Jun;40(6):981-987. doi: 10.1007/s10529-018-2545-0. Epub 2018 Apr 4.
6
Harnessing the advances of genetic engineering in microalgae for the production of cannabinoids.利用基因工程在微藻中生产大麻素的进展。
Crit Rev Biotechnol. 2023 Sep;43(6):823-834. doi: 10.1080/07388551.2022.2071672. Epub 2022 Jun 27.
7
Complete biosynthesis of cannabinoids and their unnatural analogues in yeast.在酵母中完成大麻素及其非天然类似物的全生物合成。
Nature. 2019 Mar;567(7746):123-126. doi: 10.1038/s41586-019-0978-9. Epub 2019 Feb 27.
8
The application of plant in vitro cultures in cannabinoid production.植物离体培养在大麻素生产中的应用。
Biotechnol Lett. 2018 Mar;40(3):445-454. doi: 10.1007/s10529-017-2492-1. Epub 2017 Dec 16.
9
Bioengineering studies and pathway modeling of the heterologous biosynthesis of tetrahydrocannabinolic acid in yeast.酵母中四氢大麻酸异源生物合成的生物工程研究和途径建模。
Appl Microbiol Biotechnol. 2020 Nov;104(22):9551-9563. doi: 10.1007/s00253-020-10798-3. Epub 2020 Oct 12.
10
First systematic evaluation of the potency of Cannabis sativa plants grown in Albania.首次对在阿尔巴尼亚种植的大麻植物药效进行系统评估。
Forensic Sci Int. 2012 Oct 10;222(1-3):40-6. doi: 10.1016/j.forsciint.2012.04.032. Epub 2012 May 18.

引用本文的文献

1
Rational Design and Modification of NphB for Cannabinoids Biosynthesis.理性设计和修饰 NphB 用于大麻素生物合成。
Molecules. 2024 Sep 19;29(18):4454. doi: 10.3390/molecules29184454.
2
Nepeta cataria L. (catnip) can serve as a chassis for the engineering of secondary metabolic pathways.荆芥(猫薄荷)可作为二次代谢途径工程的底盘。
Biotechnol Lett. 2024 Oct;46(5):843-850. doi: 10.1007/s10529-024-03489-w. Epub 2024 May 8.
3
Bioengineering of the Marine Diatom with Cannabis Genes Enables the Production of the Cannabinoid Precursor, Olivetolic Acid.
利用大麻基因对海洋硅藻进行生物工程改造,可生产大麻素前体橄榄苦苷酸。
Int J Mol Sci. 2023 Nov 22;24(23):16624. doi: 10.3390/ijms242316624.
4
Metabolic Engineering of to Produce Cannabinoid Precursors and Their Analogues.用于生产大麻素前体及其类似物的代谢工程。
Metabolites. 2022 Nov 25;12(12):1181. doi: 10.3390/metabo12121181.
5
New Insight into Ornamental Applications of Cannabis: Perspectives and Challenges.大麻在观赏应用方面的新见解:前景与挑战。
Plants (Basel). 2022 Sep 13;11(18):2383. doi: 10.3390/plants11182383.
6
The Origin and Biomedical Relevance of Cannabigerol.大麻萜酚的起源和生物医学相关性。
Int J Mol Sci. 2022 Jul 19;23(14):7929. doi: 10.3390/ijms23147929.
7
NMR Spectroscopy Applied to the Metabolic Analysis of Natural Extracts of .NMR 光谱学在天然提取物代谢分析中的应用。
Molecules. 2022 May 30;27(11):3509. doi: 10.3390/molecules27113509.
8
Identification of the Histone Deacetylases Gene Family in Hemp Reveals Genes Regulating Cannabinoids Synthesis.大麻中组蛋白去乙酰化酶基因家族的鉴定揭示了调控大麻素合成的基因。
Front Plant Sci. 2021 Oct 20;12:755494. doi: 10.3389/fpls.2021.755494. eCollection 2021.
9
research trends, challenges, and new-age perspectives.研究趋势、挑战及新时代观点。
iScience. 2021 Nov 1;24(12):103391. doi: 10.1016/j.isci.2021.103391. eCollection 2021 Dec 17.
10
Recalcitrance of Cannabis sativa to de novo regeneration; a multi-genotype replication study.大麻对从头再生的抗性;多基因型复制研究。
PLoS One. 2021 Aug 13;16(8):e0235525. doi: 10.1371/journal.pone.0235525. eCollection 2021.